Regulatory News Service (RNS)

View all

Results, Reports and Presentations

• Q2 2024 Results In Line with Updated Guidance; $100m Share Buyback Announced

  July 25 2024 Download (637KB)

• 2024 Jefferies Global Healthcare Conference

  June 5 2024 Download (905KB)

• Analyst Teach-in

  May 23 2024 Download (4.82MB)

• Q1 2024 Financial Results

  April 25 2024 Download (529KB)

• Annual Report and Accounts 2023

  March 13 2024 Download (15.6MB)

View all

Latest News

• Indivior Announces Q2 2024 Financial Results

  July 25 2024

• Indivior Announces a New $100 Million Share Repurchase Program; New Program will be Executed Over an Accelerated Time Frame

  July 25 2024

• Indivior Provides Business Update; Conference Call at 8:00 AM U.S. EDT

  July 9 2024

• Indivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a Synthetic Opioid Overdose on Respiratory Depression and Cardiac Arrest

  June 18 2024

• Indivior Announces Dosing of First Subject with INDV-2000 in a Phase 2 Study Assessing the Safety and Efficacy of INDV-2000 in Individuals with Opioid Use Disorder

  June 10 2024

View all